Treating Alzheimers using delipidated protein particles
Details for Australian Patent Application No. 2003268190 (hide)
International Classifications
Event Publications
8 January 2004 Complete Application Filed
Priority application(s): 60/405,922 26.08.02 US
22 April 2004 Application Open to Public Inspection
Published as AU-B-2003268190
3 April 2008 Application Accepted
Published as AU-B-2003268190
31 July 2008 Standard Patent Sealed
6 August 2009 Assignment Registered
Lipid Sciences, Inc. The patent has been assigned to Eli Lilly and Company
24 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser